Active Ingredient: EDARAVONE
Proprietary Name: RADICAVA
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 60MG/100ML (0.6MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N209176
Product Number: 002
Approval Date: Nov 15, 2018
Applicant Holder Full Name: MITSUBISHI TANABE PHARMA CORP
Marketing Status:
Prescription
Patent and Exclusivity Information
